Your browser doesn't support javascript.
loading
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.
Jain, S; Lyons, C A; Walker, S M; McQuaid, S; Hynes, S O; Mitchell, D M; Pang, B; Logan, G E; McCavigan, A M; O'Rourke, D; McArt, D G; McDade, S S; Mills, I G; Prise, K M; Knight, L A; Steele, C J; Medlow, P W; Berge, V; Katz, B; Loblaw, D A; Harkin, D P; James, J A; O'Sullivan, J M; Kennedy, R D; Waugh, D J.
Afiliação
  • Jain S; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Lyons CA; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Walker SM; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • McQuaid S; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • Hynes SO; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Mitchell DM; Department of Pathology, University Hospital Galway, Galway, Ireland.
  • Pang B; Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK.
  • Logan GE; Department of Pathology, National University Cancer Institute, Singapore.
  • McCavigan AM; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • O'Rourke D; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • McArt DG; Department of Pathology, Belfast City Hospital, Belfast, UK.
  • McDade SS; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Mills IG; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Prise KM; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Knight LA; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Steele CJ; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Medlow PW; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • Berge V; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • Katz B; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • Loblaw DA; Department of Urology, Oslo University Hospital, Oslo, Norway.
  • Harkin DP; Department of Urology, Oslo University Hospital, Oslo, Norway.
  • James JA; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • O'Sullivan JM; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
  • Kennedy RD; Almac Diagnostics, Seagoe Industrial Estate, Craigavon, UK.
  • Waugh DJ; Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK.
Ann Oncol ; 29(1): 215-222, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29045551
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biópsia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biópsia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article